BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 9227330)

  • 1. CR3-dependent phagocytosis by murine macrophages: different cytokines regulate ingestion of a defined CR3 ligand and complement-opsonized Cryptococcus neoformans.
    Cross CE; Collins HL; Bancroft GJ
    Immunology; 1997 Jun; 91(2):289-96. PubMed ID: 9227330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine enhancement of complement-dependent phagocytosis by macrophages: synergy of tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor for phagocytosis of Cryptococcus neoformans.
    Collins HL; Bancroft GJ
    Eur J Immunol; 1992 Jun; 22(6):1447-54. PubMed ID: 1601035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ingestion of acapsular Cryptococcus neoformans occurs via mannose and beta-glucan receptors, resulting in cytokine production and increased phagocytosis of the encapsulated form.
    Cross CE; Bancroft GJ
    Infect Immun; 1995 Jul; 63(7):2604-11. PubMed ID: 7790075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paradoxical role of capsule in murine bronchoalveolar macrophage-mediated killing of Cryptococcus neoformans.
    Levitz SM; DiBenedetto DJ
    J Immunol; 1989 Jan; 142(2):659-65. PubMed ID: 2521352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capsular specific IgM enhances complement-mediated phagocytosis and killing of Cryptococcus neoformans by methamphetamine-treated J774.16 macrophage-like cells.
    Aslanyan L; Ekhar VV; DeLeon-Rodriguez CM; Martinez LR
    Int Immunopharmacol; 2017 Aug; 49():77-84. PubMed ID: 28551495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opsonic requirements for dendritic cell-mediated responses to Cryptococcus neoformans.
    Kelly RM; Chen J; Yauch LE; Levitz SM
    Infect Immun; 2005 Jan; 73(1):592-8. PubMed ID: 15618199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opsonization and phagocytosis of Cryptococcus neoformans.
    Kozel TR
    Arch Med Res; 1993; 24(3):211-8. PubMed ID: 8298269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CR3 (CD11b/CD18) and CR4 (CD11c/CD18) are involved in complement-independent antibody-mediated phagocytosis of Cryptococcus neoformans.
    Taborda CP; Casadevall A
    Immunity; 2002 Jun; 16(6):791-802. PubMed ID: 12121661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phagocytosis and killing of Cryptococcus neoformans by rat alveolar macrophages in the absence of serum.
    Bolaños B; Mitchell TG
    J Leukoc Biol; 1989 Dec; 46(6):521-8. PubMed ID: 2681492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody action after phagocytosis promotes Cryptococcus neoformans and Cryptococcus gattii macrophage exocytosis with biofilm-like microcolony formation.
    Alvarez M; Saylor C; Casadevall A
    Cell Microbiol; 2008 Aug; 10(8):1622-33. PubMed ID: 18384661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The beta-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells.
    Xia Y; Vetvicka V; Yan J; Hanikýrová M; Mayadas T; Ross GD
    J Immunol; 1999 Feb; 162(4):2281-90. PubMed ID: 9973505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissimilar and similar functional properties of complement receptor-3 in microglia and macrophages in combating yeast pathogens by phagocytosis.
    Hadas S; Reichert F; Rotshenker S
    Glia; 2010 May; 58(7):823-30. PubMed ID: 20091776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of granulocyte macrophage colony-stimulating factor in host defense against pulmonary Cryptococcus neoformans infection during murine allergic bronchopulmonary mycosis.
    Chen GH; Olszewski MA; McDonald RA; Wells JC; Paine R; Huffnagle GB; Toews GB
    Am J Pathol; 2007 Mar; 170(3):1028-40. PubMed ID: 17322386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of granulocyte-macrophage colony-stimulating factor on rat alveolar macrophage anticryptococcal activity in vitro.
    Chen GH; Curtis JL; Mody CH; Christensen PJ; Armstrong LR; Toews GB
    J Immunol; 1994 Jan; 152(2):724-34. PubMed ID: 8283047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated neutrophils exhibit enhanced phagocytosis of Cryptococcus neoformans opsonized with normal human serum.
    Kozel TR; Pfrommer GS; Redelman D
    Clin Exp Immunol; 1987 Oct; 70(1):238-46. PubMed ID: 2961491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryptococcus neoformans and Cryptococcus gattii clinical isolates from Thailand display diverse phenotypic interactions with macrophages.
    Hansakon A; Mutthakalin P; Ngamskulrungroj P; Chayakulkeeree M; Angkasekwinai P
    Virulence; 2019 Dec; 10(1):26-36. PubMed ID: 30520685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor-mediated recognition of Cryptococcus neoformans.
    Levitz SM
    Nihon Ishinkin Gakkai Zasshi; 2002; 43(3):133-6. PubMed ID: 12145626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell-dependent activation of macrophages and enhancement of their phagocytic activity in the lungs of mice inoculated with heat-killed Cryptococcus neoformans: involvement of IFN-gamma and its protective effect against cryptococcal infection.
    Kawakami K; Kohno S; Kadota J; Tohyama M; Teruya K; Kudeken N; Saito A; Hara K
    Microbiol Immunol; 1995; 39(2):135-43. PubMed ID: 7783686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of interleukin-6 mRNA in rat alveolar macrophages by in vitro exposure to both Cryptococcus neoformans and anti-C. neoformans antiserum.
    Li RK; Mitchell TG
    J Med Vet Mycol; 1997; 35(5):327-34. PubMed ID: 9402525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CR3 (CD11b/CD18) is the major macrophage receptor for IgM antibody-mediated phagocytosis of African trypanosomes: diverse effect on subsequent synthesis of tumor necrosis factor alpha and nitric oxide.
    Pan W; Ogunremi O; Wei G; Shi M; Tabel H
    Microbes Infect; 2006 Apr; 8(5):1209-18. PubMed ID: 16616573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.